Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action
The DOI matches its Crossref record, with a small difference in title or year; 125 of the 125 references it cites were found in a registry or an index.
Abstract
Acamprosate is an abstinence-promoting drug widely used in the treatment of alcohol dependence but which has a mechanism of action that has remained obscure for many years. Recently, evidence has emerged that this drug may interact with excitatory glutamatergic neurotransmission in general and as an antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5) in particular. These findings provide, for the first time, a satisfactory, unifying hypothesis that can bring together and explain the diverse neurochemical effects of acamprosate. Glutamic acid is involved in several aspects of alcohol dependence and withdrawal, many of which can be modified by acamprosate. For example, during chronic exposure to alcohol, the glutamatergic system becomes upregulated, leaving the brain exposed to excessive glutamatergic activity when alcohol is abruptly withdrawn. The surge in glutamic acid release that occurs following alcohol withdrawal can be attenuated by acamprosate. The elevated extracellular levels of glutamic acid observed in withdrawal, together with supersensitivity of NMDA receptors, may expose vulnerable neurons to excitotoxicity, possibly contributing to the neuronal loss sometimes observed in chronic alcohol dependence. In vitro studies suggest that the excitotoxicity produced by ethanol can effectively be blocked by acamprosate. Moreover, glutamatergic neurotransmission plays an important role in the acquisition of cue-elicited drinking behaviours, which again can…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Protracted abstinence, largely described in alcohol dependence models, appears to involve overactive glutamatergic and CRF systems.99,100”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [99]
Citations
Cites
Hebb, D. O. (2005) · doi:10.4324/9781410612403 · Cited by 9,825
Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.
Squire, L. R. (1992) · Psychological Review · doi:10.1037/0033-295x.99.2.195 · Cited by 5,376
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J.-P. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,081
The human hippocampus and spatial and episodic memory
Burgess, N., Maguire, E. A., & O'Keefe, J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00830-9 · Cited by 2,401
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Ethanol Inhibits NMDA-Activated Ion Current in Hippocampal Neurons
Lovinger, D. M., White, G., & Weight, F. F. (1989) · Science · doi:10.1126/science.2467382 · Cited by 1,448
Kainic acid as a tool in neurobiology
McGeer, E. G., Olney, J. W., & McGeer, P. L. (1978) · Raven Press eBooks · Cited by 1,308
Excitotoxity and the NMDA receptor
Rothman, S. M., & Olney, J. W. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90177-9 · Cited by 1,058
Research works printed but not linked: 22
- Pelc, 2002, Alcohol Clin Exp Res, 26, 1529, 10.1111/j.1530-0277.2002.tb02452.x · doi:10.1111/j.1530-0277.2002.tb02452.x
- Iorio, 1992, Mol Pharmacol, 41, 1142
- Harris, 1999, Alcohol Clin Exp Res, 23, 1563
- Leidenheimer, 1992, Adv Biochem Psychopharmacol, 47, 269
- Kumari, 2000, Prog Drug Res, 54, 152
- Masood, 1994, Mol Pharmacol, 45, 324
- Simson, 1991, J Pharmacol Exp Ther, 257, 225
- Dildy-Mayfield, 1992, J Pharmacol Exp Ther, 262, 487
- Smothers, 1997, J Pharmacol Exp Ther, 283, 1214
- Davidson, 1998, Alcohol Clin Exp Res, 22, 1205
- Mhatre, 1993, Alcohol Alcohol Suppl, 2, 331
- Devaud, 1995, Mol Pharmacol, 48, 861
- Zeise, 1990, Prog Clin Biol Res, 351, 237
- Berton, 1998, Alcohol Clin Exp Res, 22, 183, 10.1111/j.1530-0277.1998.tb03636.x · DOI
- Naassila, 1998, Alcohol Clin Exp Res, 22, 802, 10.1111/j.1530-0277.1998.tb03871.x · doi:10.1111/j.1530-0277.1998.tb03871.x · Paper page
- al Qatari, 1998, Alcohol Clin Exp Res, 22, 810, 10.1111/j.1530-0277.1998.tb03872.x · doi:10.1111/j.1530-0277.1998.tb03872.x · Paper page
- Booth, 1993, Alcohol Alcohol, 28, 593
- Dahchour, 2001, ddictologie, 23, 437
- Schmidt, 1994, J Neural Transm Suppl, 43, 63
- Prendergast, 2000, Alcohol Clin Exp Res, 24, 1855, 10.1111/j.1530-0277.2000.tb01990.x · doi:10.1111/j.1530-0277.2000.tb01990.x · Paper page
- Prendergast, 2000, Alcohol Clin Exp Res, 24, 1583, 10.1111/j.1530-0277.2000.tb04578.x · doi:10.1111/j.1530-0277.2000.tb04578.x · Paper page
- Paille, 1995, Alcohol Alcohol, 30, 239
Cited by
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
“Protracted abstinence, largely described in alcohol dependence models, appears to involve overactive glutamatergic and CRF systems, presumably in the extended amygdala, although to a large extent this remains to be explored (de Witte et al, 2005; Valdez et al, 2002).”
BackgroundSelf-citationNeurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698
Self-citationAddiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
“Protracted abstinence, largely described in alcoholdependence models, appears to involve overactive glutamatergic and CRF systems (De Witte et al. 2005, Valdez et al. 2002).”
BackgroundSelf-citationG protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
The changing opioid crisis: development, challenges and opportunities
Volkow, N. D., & Blanco, C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0661-4 · Cited by 522
Metadata
- Authors
- De Witte, P., Littleton, J., Parot, P., & Koob, G.
- Affiliations
- University of Kentucky (US)
- Scripps Research Institute (US)
- ORCID
- Koob, George
- Venue
- CNS Drugs
- Published
- 2005
- Volume
- 19
- Issue
- 6
- Pages
- 517-537
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W2005949458
- Semantic Scholar
- e09c4ded259fa38fa1393852509d1be86c8e9451
- Cited by
- 201
- References
- 124
- Citations by year
- 2026: 6 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 8 · 2019: 8 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 9 · 2014: 11 · 2013: 13 · 2012: 12
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Keywords
- acamprosate, alcoholism, alcohol withdrawal, glutamatergic neurotransmission, metabotropic glutamate receptor 5, neuroprotection, excitotoxicity, neuronal loss
- MeSH terms
- Acamprosate, Ethanol, Alcoholism, Animals, Drug Interactions, Humans, Models, Biological, Taurine, Receptors, Glutamate, Neuroprotective Agents, Excitatory Amino Acids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action. https://app.cochat.ai/papers/10.2165/00023210-200519060-00004
- The paper
- De Witte, P., Littleton, J., Parot, P., & Koob, G. (2005). Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action. CNS Drugs. https://doi.org/10.2165/00023210-200519060-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.